Literature DB >> 10194858

Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers.

A Voigt1, F Zintl.   

Abstract

The main disadvantages of foetal calf serum as the world-wide common serum supplement for cell growth are its content of various proteins of variable concentrations between batches as well as its high cost. The use of serum-free and protein-free media is gradually becoming one of the goals of cell culture especially for standardizing culture conditions or for simple purification of cell products like monoclonal antibodies. The mouse hybridoma cells 14/2/1 were cultivated either in protein-free UltraDOMA medium or in serum-containing RPMI medium with and without microcarriers to generate high quantities of monoclonal antibodies against neuroblastoma tumour cells. Cell growth rate, IgG production, viability, glucose and lactate concentrations, attachment rate and doubling time have been used as investigation criteria. Modifications of culture procedures (static or stirred), inoculum density, and microcarrier concentration caused an improvement of monoclonal antibody production. The kinetics of antibody synthesis was best in spinner culture with 2 ml of microcarriers in protein-free medium. These results of short-term microcarrier culture in stirred spinner flasks indicate that IgG yields in protein-free medium 2.5-fold higher to those in serum-supplemented medium can be achieved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194858     DOI: 10.1016/s0168-1656(98)00208-9

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  9 in total

1.  A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor.

Authors:  Ming-Bo Sun; Yan-Jun Jiang; Wei-Dong Li; Ping-Zhong Li; Guo-Liang Li; Shu-De Jiang; Guo-Yang Liao
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

2.  Analysis of kinetic, stoichiometry and regulation of glucose and glutamine metabolism in hybridoma batch cultures using logistic equations.

Authors:  María Lourdes Acosta; Asterio Sánchez; Francisco García; Antonio Contreras; Emilio Molina
Journal:  Cytotechnology       Date:  2007-08-18       Impact factor: 2.058

3.  Comparative investigation of the use of various commercial microcarriers as a substrate for culturing mammalian cells.

Authors:  Duygu Ayyildiz-Tamis; Kamuran Avcı; S Ismet Deliloglu-Gurhan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-12-20       Impact factor: 2.416

4.  Lysine: Is it worth more?

Authors:  D Datta; A Bhinge; V Chandran
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

5.  Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier.

Authors:  Nan-Hong Tang; Yian-Ling Chen; Xiao-Qian Wang; Xiu-Jin Li; Feng-Zhi Yin; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

6.  Detachment factors for enhanced carrier to carrier transfer of CHO cell lines on macroporous microcarriers.

Authors:  K Landauer; M Dürrschmid; H Klug; S Wiederkum; G Blüml; O Doblhoff-Dier
Journal:  Cytotechnology       Date:  2002-05       Impact factor: 2.058

7.  The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.

Authors:  Ana Rita Costa; Joanne Withers; Maria Elisa Rodrigues; Niaobh McLoughlin; Mariana Henriques; Rosário Oliveira; Pauline M Rudd; Joana Azeredo
Journal:  Springerplus       Date:  2013-01-28

8.  Three-Dimensional Culture of Hybridoma Cells Secreting Anti-Human Chorionic Gonadotropin by a New Rolling Culture System.

Authors:  Yan Wang; Hong-Li Jiao; Jin-Zhu Zhang; Rong-Qiao He
Journal:  J Biomed Biotechnol       Date:  2004

9.  Monoclonal Antibody Production Against Vimentin by Whole Cell Immunization in a Mouse Model.

Authors:  Marzieh Rezaei; Abbas Ghaderi
Journal:  Iran J Biotechnol       Date:  2018-05-15       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.